Revvity, Inc.: Form 10-Q for the period ended Apr 2, 2023
Filed with the SEC on May 12, 2023 and accepted by EDGAR at May 12, 2023, 14:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-04-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-02 to 2023-04-02 | $674.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-01-02 to 2023-04-02 | $293.5m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2023-01-02 to 2023-04-02 | $56.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-01-02 to 2023-04-02 | $248.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-02 to 2023-04-02 | $76.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-02 to 2023-04-02 | $22.7m | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-02 to 2023-04-02 | $4.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-02 to 2023-04-02 | $569.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-02 to 2023-04-02 | $4.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-02 to 2023-04-02 | $4.51 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-02 to 2023-04-02 | 126,469,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-01-02 to 2023-04-02 | $63.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-01-02 to 2023-04-02 | $20.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2023-01-02 to 2023-04-02 | $8.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2023-01-02 to 2023-04-02 | $61.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-04-02 | $2.27bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-04-02 | $3.80bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-04-02 | $14.64bn | us-gaap:Assets |
| Current liabilities | At period end2023-04-02 | $1.56bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-04-02 | $6.60bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-04-02 | $3.88bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-04-02 | $479.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-04-02 | $8.03bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000031791-23-000008. Last ingested by Listed: Nov 3, 2026, 08:38 ET. Listed shows no prices and gives no investment advice.